86.21.Z - General medical practice activities
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
84.12.Z - Regulation of the activities of providing health care, education, cultural services and other social services, excluding social security
86.22.Z - Specialist medical practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0 | 0,2 | 851,7 |
EBITDA | 0,1 | 0 | 0,2 | 698,7 |
Short time liabilities | 0,2 | 0,2 | 0,3 | 36,5 |
Equity capital | 0 | 0,1 | 0,2 | 292 |
Operating profit (EBIT) | 0,1 | 0 | 0,2 | 854,9 |
Assets | 0,4 | 0,4 | 0,6 | 29,6 |
Net profit (loss) | 0,1 | 0 | 0,2 | 640,2 |
Cash | 0,3 | 0,4 | 0,5 | 29,6 |
Net income from sale | 1,9 | 2,3 | 2,9 | 25,5 |
Liabilities and provisions for liabilities | 0,3 | 0,4 | 0,3 | -12,4 |
Working assets | 0,4 | 0,4 | 0,6 | 31,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 163,4 | 39,4 | 74,5 | 35,1 |
Equity capital to total assets | 9,8 | 13,8 | 41,8 | 28 |
Gross profit margin | 3,9 | 0,9 | 7,2 | 6,3 |
EBITDA Margin | 4 | 1,2 | 7,4 | 6,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 38 | 41 | 3 |
Current financial liquidity indicator | 1.7934656143188477 | 1.7886627912521362 | 1.7171224355697632 | -0,1 |
Net dept to EBITDA | -1.6250442266464233 | -8.156232833862305 | -2.152864933013916 | 6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane